MARKETBEAM.IO PLATFORM

FDA-Ready Social Media Management for Life Sciences

From first post to final audit. MarketBeam helps pharmaceutical, biotechnology, medical device, and life sciences organizations manage social media compliance through AI-powered content checks, controlled MLR approval workflows, compliant publishing, adverse event monitoring, and audit-ready documentation.

BUILT FOR COMPLIANT SCALE

Social Media Moves Fast. FDA Responsibilities Do Not Disappear.

Pharmaceutical and life sciences companies are expected to communicate product information accurately, responsibly, and consistently across every digital channel.

That responsibility applies whether content is published by a corporate brand account, an employee, an executive, an agency, a healthcare professional, a patient advocate, or a paid influencer.

MarketBeam embeds compliance controls directly into the social media workflow, helping teams identify potential issues before publication and maintain control after content goes live.

What Is FDA Social Media Compliance?

FDA social media compliance refers to the processes pharmaceutical, biotechnology, and medical device companies use to ensure that digital communications follow applicable U.S. Food and Drug Administration expectations.

For prescription drug promotion, the FDA’s Office of Prescription Drug Promotion (OPDP) evaluates whether promotional communications are truthful, balanced, adequately supported, and consistent with approved product labeling.

Instagram

X / Twitter

YouTube

TikTok

Paid Advertising

The Most Common FDA Social Media Risk Areas

Social media speeds up communications, but also multiplies regulatory exposure. Without centralized governance, compliance errors become common.

Unsupported Claims

Promotional content may create risk when it communicates efficacy, superiority, safety, convenience, or patient outcomes that are not adequately supported.

Missing Risk Info

A post may emphasize product benefits while omitting important safety information, contraindications, warnings, or limitations.

Inadequate Fair Balance

Fair balance requires benefit information and risk information to be presented with appropriate prominence, layout, and readability.

Off-Label Promotion

Content may create regulatory risk when it suggests a use, population, dosage, outcome, or treatment context outside the approved label.

Version Control Errors

Last-minute edits, shortened captions, altered images, or missing disclosures can lead to publishing a different version than the MLR-approved one.

Platform Truncation

Important safety information may be hidden, truncated, separated from benefit claims, or rendered differently across dynamic social feeds.

Employee Advocacy

Employees may unintentionally modify approved content, add personal claims, use outdated material, or omit required disclosures.

Influencer Marketing Risk

Influencers, creators, and advocates may publish content that lacks adequate FDA disclosures, risk details, or approved brand messaging.

Adverse Event Exposure

Patients discussing side effects, complaints, or problems in comments require fast, structured identification and pharmacovigilance escalation.

What Can Happen Without a Controlled Workflow?

Compare the fragmented, risky process used by marketing agencies against MarketBeam’s unified compliance engine.

Content Drafted by Agency

Content created in silos via spreadsheets, emails, and shared documents.

Agency Revises the Message

Edits are made directly on drafts without version-control checks.

MLR Reviews an Outdated Version

Reviewers comment on a PDF draft that does not match the actual publish file.

A Different Version is Published

Last-minute caption changes occur directly in scheduling tool, leaving risk information missing.

Unmonitored Comments & Side Effects

A patient reports a side effect in comments. The community manager misses it, and it goes unescalated.

Audit Trail Failure

The organization cannot reproduce history during audit, resulting in regulatory action.

Create

AI PreCheck

MLR Review

Approve

Publish

Monitor

Audit

1. Content Creation

Draft social content, campaigns, and creatives directly in a collaborative, workspace dashboard built specifically for compliance parameters.

2. AI Regulatory PreCheck

Evaluate messaging against clinical claims, warnings, off-label keywords, character limits, and image text layouts before sending to MLR.

3. Medical, Legal, & Regulatory (MLR) Review

Structured parallel review streams based on product brand guidelines, avoiding fragmented email lists and comment errors.

4. Expiration & Approval Signoff

Lock the final copy and visual assets, assign explicit expiration boundaries, and output status records.

5. Direct Secure Publishing

Connect live scheduling arrays directly to approved asset codes. Restricted publishing guards prevent unapproved versions.

6. Adverse Event & Sentiment Triage

Continuously scan live comments, direct messages, and brand mentions for patient feedback, side-effects, and quality complaints.

7. Full Regulatory Audit Reports

Maintains absolute compliance trails mapping dates, edits, comments, approvals, and live publishing links for OPDP review.

Adverse Event & Complaint Monitoring

Every comment matters. AI-driven social listening flags potential patient side effects and complaints, feeding them directly into your safety workflow.

Detect

Assign

Audit

Incoming Social Conversations

@patient_advocate_mary Instagram Comment • 2m ago

I’ve been taking Novagen for a week now. Efficacy is good but I started having severe dizziness and a rash on my arm. Is this normal?

AI Warning: Potential Adverse Event (AE) identified.

PV Detection and Routing

Triage Stage

1. Detect & Classify

Identified Keywords

“dizziness”, “rash”

Assignee / Target System

Pending PV Validation

Social comments are also evaluated for packaging damage, broken delivery items, labeling discrepancies, storage conditions, or product malfunctions, ensuring regulatory safety requirements are met across the board.

MarketBeam AI Compliance Architecture

This infographic illustrates the MarketBeam AI Compliance Engine, an intelligent platform that enables compliant social media communication for life sciences organizations by combining internal business knowledge with external regulatory guidance.

Out of the Box Inputs

Custom Inputs

Internal
Policies

Corp Comms

Brand Guide

Label Info

DS Info

Regulatory Bodies

Regulatory
Bodies

FDA

WHO

AI Compliance Engine

Compliance Pre-Checks

Fact-Check and Contextual Match

Image Analysis

AI Detection

Auto-Community Management

Video Analysis Roadmap

Enterprise Sync

Veeva Vault PromoMats Integration

For organizations using Veeva Vault PromoMats, MarketBeam bridges approved medical assets with social media scheduling. Reduce duplicate uploads, synchronize claim libraries, track asset expirations, and maintain digital version integrity.

Auto-sync approved materials Keep version history locked

Veeva Vault PromoMats

MLR Approved

MarketBeam Social Sync

FDA Ready

MLR Approval Workflows

Route assets dynamically based on therapeutic area, market channels, or campaign risk.

Employee Advocacy

Unlock safe sharing: employees distribute pre-approved messages without altering compliance details.

Influencer Governance

Track sponsored creator copy, disclosures, dynamic campaign timelines, and approval status.

FDA Form 2253 Support

Assemble historical approval packages, dates, and creatives automatically for FDA submission.

Reduce Risk Across the Entire Content Lifecycle

MarketBeam embeds compliance control points directly into the social workflow, replacing

fragmented tracking with locked records.

Content Stage

Without MarketBeam

With MarketBeam

Before & After

Reduce Risk Across the Entire Content Lifecycle

MarketBeam embeds compliance control points directly into the social workflow, replacing fragmented tracking with locked records.

Content Stage	Without MarketBeam	With MarketBeam
Claims	High-Risk Language Writers and external agencies may use unsupported, unapproved, or outdated efficacy claims.	AI PreCheck Alignment Instant scans catch exaggeration and check proposed claims against approved reference catalogs.
Fair Balance	Mismatched Prominence Benefit statements are highlighted while safety disclosures are minimized or separated.	Structural Warnings AI analyzes contrast and proximity, ensuring benefit claims are balanced with necessary risks.
MLR Review	Fragmented Emails Review cycles require manual spreadsheets, email chains, and disconnected PDF copies.	Centralized Engine Routing rules direct assets to medical, legal, and regulatory leads inside a single platform.
Version Control	Mismatched Publishing Last-minute scheduling changes create inconsistencies between approved and published versions.	Version-Locking Gate The final approved asset is locked, connecting approval directly to live scheduler publishing.
Influencer Campaigns	Post-Pub Reviews Influencer assets are published directly, lacking disclosures or MLR signoff reviews.	Pre-Pub Governance Influencers submit materials through MarketBeam portals, gating posts until review parameters pass.

Built for Companies Bringing New Products to Market

Commercialization teams launch campaigns under immense time pressure, managing agency content and executive visibility while labels and claims evolve. MarketBeam helps launch teams build regulatory control lines from day one:

> Launch-specific AI PreCheck parameters

> Approved product & claim libraries

> Veeva PromoMats sync integration

> Adverse event capture from day one

Built for Companies Bringing New Products to Market

> Launch-specific AI PreCheck parameters

> Approved product & claim libraries

> Veeva PromoMats sync integration

> Adverse event capture from day one

Quantified Business Outcomes

Enable secure marketing outreach while accelerating compliance pipelines and protecting brand integrity.